Walder Wyss advised SixPeaks Bio AG while Lenz & Staehelin acted as Swiss counsel to AstraZeneca. SixPeaks Bio AG has secured USD30 million in Series A...
You must be a Standard 1 Year member to access this content.
Lenz & Staeeelin advised Venturi Partners on the deal. Venturi Partners, a prominent growth equity firm specialising in consumer investments across India and Southeast Asia, announced...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin advised Starrag Group Holding AG and Tornos Holding AG on their merger. The two traditional Swiss precision machine tool manufacturers Starrag and Tornos,...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin has advised Nordic BioSite Group in this acquisition; Wenger Plattner acted for LubioScience. Nordic BioSite Group, a portfolio company of Adelis Equity Partners, has acquired LubioScience,...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin advised the selling shareholders of RIRI Group in this transaction. Homburger advised OC Oerlikon. Oerlikon, a global innovation provider for surface engineering, polymer...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin advised On Holding AG on the deal. Homburger advised the underwriters. On Holding AG, a Swiss-based athletic shoe and performance sportswear company, successfully...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin advised Vicat and Vigier Holding in this transaction. MLL advised Müller-Steinag. Vicat Group, the Euronext listed producer of cement, concrete and aggregates announced...
You must be a Standard 1 Year member to access this content.
